Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
370.00
307.00
251.00
456.00
262.00
139.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
370.00
307.00
251.00
456.00
262.00
139.00
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
-1.00
-3.00
-2.00
0.00
-5.00
Raw Materials Consumed
181.00
154.00
113.00
203.00
165.00
92.00
Power & Fuel Cost
23.00
17.00
12.00
11.00
6.00
4.00
Employee Cost
43.00
32.00
29.00
20.00
15.00
11.00
Operating Expenses
3.00
6.00
5.00
4.00
3.00
2.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
16.00
7.00
12.00
27.00
24.00
9.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
2.00
2.00
1.00
0.00
1.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
289.00
240.00
190.00
284.00
233.00
125.00
Operating Profit (PBDIT) excl Other Income
80.00
66.00
60.00
171.00
28.00
14.00
Other Income
1.00
1.00
2.00
3.00
1.00
3.00
Operating Profit (PBDIT)
82.00
68.00
63.00
175.00
30.00
17.00
Interest
9.00
10.00
6.00
2.00
2.00
2.00
Profit before Depriciation and Tax
72.00
57.00
57.00
172.00
27.00
15.00
Depreciation
18.00
19.00
14.00
10.00
6.00
4.00
Profit Before Taxation & Exceptional Items
54.00
38.00
42.00
161.00
21.00
10.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
54.00
31.00
25.00
161.00
21.00
10.00
Provision for Tax
14.00
7.00
6.00
41.00
6.00
2.00
Profit After Tax
39.00
23.00
19.00
119.00
14.00
8.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
202.00
179.00
160.00
42.00
26.00
17.00
Profit Available for appropriations
242.00
203.00
179.00
162.00
41.00
25.00
Appropriations
242.00
203.00
179.00
162.00
41.00
25.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
38.36
22.76
18.16
115.12
14.60
8.02
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 20.52% vs 22.36% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 21.22% vs 9.20% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -4.90% vs 57.19% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 68.54% vs 22.49% in Mar 2024
Compare Profit and Loss Results of Kwality Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
370.00
405.00
-35.00
-8.64%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
370.00
405.00
-35.00
-8.64%
Expenditure (Ex Depriciation)
Stock Adjustments
1.00
-17.00
18.00
105.88%
Raw Materials Consumed
181.00
149.00
32.00
21.48%
Power & Fuel Cost
23.00
11.00
12.00
109.09%
Employee Cost
43.00
96.00
-53.00
-55.21%
Operating Expenses
3.00
20.00
-17.00
-85.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
16.00
31.00
-15.00
-48.39%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
26.00
-24.00
-92.31%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
289.00
356.00
-67.00
-18.82%
Operating Profit (PBDIT) excl Other Income
80.00
49.00
31.00
63.27%
Other Income
1.00
4.00
-3.00
-75.00%
Operating Profit (PBDIT)
82.00
53.00
29.00
54.72%
Interest
9.00
10.00
-1.00
-10.00%
Profit before Depriciation and Tax
72.00
43.00
29.00
67.44%
Depreciation
18.00
9.00
9.00
100.00%
Profit Before Taxation & Exceptional Items
54.00
33.00
21.00
63.64%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
54.00
39.00
15.00
38.46%
Provision for Tax
14.00
9.00
5.00
55.56%
Profit After Tax
39.00
23.00
16.00
69.57%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
202.00
231.00
-29.00
-12.55%
Profit Available for appropriations
242.00
261.00
-19.00
-7.28%
Appropriations
242.00
261.00
-19.00
-7.28%
Equity Dividend (%)
0%
50%
-50.00
Earnings Per Share
38.36
3.24
35.12
1,083.95%
Profit And Loss - Net Sales
Net Sales 370.20 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.52% vs 22.36% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 80.39 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.22% vs 9.20% in Mar 2024
Profit And Loss - Interest
Interest 9.88 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -4.90% vs 57.19% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 39.80 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 68.54% vs 22.49% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
